TAXOTERE

Country: Israel

Bahasa: Inggeris

Sumber: Ministry of Health

Bahan aktif:

DOCETAXEL AS TRIHYDRATE 20 MG / 1 ML

Boleh didapati daripada:

SANOFI - AVENTIS ISRAEL LTD

Kod ATC:

L01CD02

Borang farmaseutikal:

CONCENTRATE FOR SOLUTION FOR INFUSION

Laluan pentadbiran:

I.V

Dikeluarkan oleh:

SANOFI - AVENTIS DEUTSCHLAND GMBH, GERMANY

Kumpulan terapeutik:

DOCETAXEL

Tanda-tanda terapeutik:

Breast cancer: Taxotere (docetaxel) in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node- positive breast cancer. Taxotere (docetaxel) in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition. Taxotere(docetaxel) monotherapy is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic therapy. Previous chemotherapy should have included an anthracycline or an alkylating agent. Taxotere (docetaxel) in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumors overexpress HER2 and who previously have not received chemotherapy for metastatic disease. Taxotere (docetaxel) in combination with capecitabine is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic chemotherapy.

Tarikh kebenaran:

2012-11-01